loadpatents
name:-0.020880937576294
name:-0.014260053634644
name:-0.011806011199951
Tellers; David M. Patent Filings

Tellers; David M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tellers; David M..The latest application filed is for "3-(1h-pyrazol-4-yl)pyridine allosteric modulators of the m4 muscarinic acetylcholine receptor".

Company Profile
13.18.26
  • Tellers; David M. - Lansdale PA
  • Tellers; David M. - West Point PA
  • TELLERS; David M. - Landsdale PA
  • Tellers; David M. - Cranford NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 11,339,156 - Acton, III , et al. May 24, 2
2022-05-24
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20210395224 - Acton, III; John J. ;   et al.
2021-12-23
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20210380580 - ACTON, III; John J. ;   et al.
2021-12-09
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 11,149,036 - Acton, III , et al. October 19, 2
2021-10-19
5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 10,981,902 - Bao , et al. April 20, 2
2021-04-20
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 10,933,056 - Acton, III , et al. March 2, 2
2021-03-02
Short Interfering Nucleic Acid (sina) Compositions
App 20200392499 - Carr; Brian Allen ;   et al.
2020-12-17
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20200207758 - ACTON, III; John J. ;   et al.
2020-07-02
Short interfering nucleic acid (siNA) compositions
Grant 10,689,648 - Carr , et al.
2020-06-23
5-(pyridin-3-yl)oxazole Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20200109137 - BAO; Jianming ;   et al.
2020-04-09
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20200069671 - Acton, III; John J. ;   et al.
2020-03-05
Dual molecular delivery of oligonucleotides and peptide containing conjugates
Grant 10,532,068 - Colletti , et al. Ja
2020-01-14
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 10,512,638 - Rudd , et al. Dec
2019-12-24
Peptide containing conjugates for dual molecular delivery of oligonucleotides
Grant 10,239,957 - Colletti , et al.
2019-03-26
Dual Molecular Delivery Of Oligonucleotides And Peptide Containing Conjugates
App 20190015442 - Colletti; Steven L. ;   et al.
2019-01-17
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20190000824 - Acton, III; John J. ;   et al.
2019-01-03
Dual molecular delivery of oligonucleotides and peptide containing conjugates
Grant 10,010,562 - Colletti , et al. July 3, 2
2018-07-03
SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
App 20180105812 - Carr; Brian Allen ;   et al.
2018-04-19
Dual Molecular Delivery Of Oligonucleotides And Peptide Containing Conjugates
App 20170189441 - Colletti; Steven L. ;   et al.
2017-07-06
Novel Single Chemical Entities And Methods For Delivery Of Oligonucleotides
App 20170137815 - COLLETTI; Steven L. ;   et al.
2017-05-18
Peptide Containing Conjugates For Dual Molecular Delivery Of Oligonucleotides
App 20170081425 - Colletti; Steven L. ;   et al.
2017-03-23
Novel Single Chemical Entities And Methods For Delivery Of Oligonucleotides
App 20160074525 - COLLETTI; Steven L. ;   et al.
2016-03-17
Novel Ph -switchable Peptides For Membrane Insertion And Pore Formation
App 20150374844 - DEGRADO; William ;   et al.
2015-12-31
SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
App 20150299696 - Carr; Brian Allen ;   et al.
2015-10-22
Poly(amide) polymers for the delivery of oligonucleotides
Grant 8,987,377 - Barrett , et al. March 24, 2
2015-03-24
Single chemical entities and methods for delivery of oligonucleotides
Grant 8,691,580 - Aaronson , et al. April 8, 2
2014-04-08
Processes for preparing protease inhibitors of hepatitis C virus
Grant 8,637,449 - Song , et al. January 28, 2
2014-01-28
Novel Single Chemical Entities And Methods For Delivery Of Oligonucleotides
App 20130253168 - Colletti; Steven L. ;   et al.
2013-09-26
Poly(amide) Polymers For The Delivery Of Oligonucleotides
App 20130253135 - Barrett; Stephanie E. ;   et al.
2013-09-26
Novel Single Chemical Entities And Methods For Delivery Of Oligonucleotides
App 20130041133 - Aaronson; Jeffrey G. ;   et al.
2013-02-14
Processes For Preparing Protease Inhibitors Of Hepatitis C Virus
App 20120232247 - Song; Zhiguo Jake ;   et al.
2012-09-13
Asymmetric hydrogenation process
Grant 7,576,118 - Tellers , et al. August 18, 2
2009-08-18
Process for preparing 3-chloromethyl-1,2,4-triazolin-5-one
Grant 7,235,671 - Seibert , et al. June 26, 2
2007-06-26
Process for preparing 3-chloromethyl-1,2,4-triazolin-5-one
App 20060052355 - Seibert; Kevin ;   et al.
2006-03-09
Asymmetric hydrogenation process
App 20050222428 - Tellers, David M. ;   et al.
2005-10-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed